Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P....

16
From Access to Engagement: Measuring Retention in Outpatient HIV Clinical Care Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS PATIENT CARE and STDs

Transcript of Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P....

Page 1: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.

From Access to Engagement: Measuring Retention in Outpatient HIV Clinical Care

Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH,and Thomas P. Giordano, M.D., M.P.H.Volume 24, Number 10, 2010AIDS PATIENT CARE and STDs

Page 2: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.

Introduction

Access to care has long been recognized as a vital factor in promoting and sustaining healthengagement means the processes of linkage to care and retention in care

Page 3: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.

Introduction

EngagementDelayed linkage and poor retention in outpatient HIV care → delayed receipt of antiretroviral medications, higher rates of viral load failure, and increased morbidity and mortalitypatients engaged in clinical care, better retention →

reduced risk transmission, viral load suppressionRetention in care is being recognized as a crucial step in maximizing patient outcomes

Page 4: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.

Methods

We reviewed the available published literature and summarized findings of the most commonly used measures to ascertain retention in outpatient HIV medicalMeasures of retention in care – Studies have typically included only scheduled outpatient medical appointmentsHIV biomarkers have been used to measure linkage and retention in HIV care, acting as a surrogate for a completed visit

Page 5: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.

Methods

Page 6: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.

MethodsMissed visits

1, 4, 0, 1Appointment adherence

80%, 33%, 100%, 66%Visit constancy

100%, 50%, 75%, 25%Gaps in care

B, D had a gap of over 6 monthsHRSA HAB medical visits performance measure

A, B, and C had 2 visits, D not

Page 7: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.

Discussion

Page 8: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.

Discussion

The clinician’s perspectivemissed visits and gap in care as intuitive measures of retentionPatient’s patterns of missed visits are likely taken into account by providers in determining the time interval for a subsequent clinic visitstudies have shown these 2 measures associated with patient outcomes including clinical events and mortality.

Page 9: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.

Discussion

The administrator’s perspectiveAppointment adherence and HRSA HAB may be preferable for administratorsallow for longitudinal tracking of retention in care and also for setting an overall clinic benchmark (e.g., >80%)inform local, regional and/or national planning and resource allocation

Page 10: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.

Discussion

Researcher’s perspectiveThe missed visits measure has been widely used particularly for preliminary research and short-term observation periods.appointment adherence and visit constancy may be preferable for research purposes, particularly for longer observation periods

Page 11: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.

Discussion

Requisite clinic visit datavisit constancy, gaps in care, and the HRSA HAB are calculated based on completed visits onlyonly ‘‘no show’’ visits have been included in the missed visit and appointment adherence, but there are issues related to the timing of cancelled visits worth noting

Page 12: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.

Discussion

Impact of clinic scheduling practicesClinics with automatic rescheduling of missed visits may lead to artificially poor missed visit and appointment adherence resultsConsiderable variability exists among HIV clinics in the availability and approach to handling unscheduled or acute care visits

Page 13: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.

Discussion

Computational issuesmissed visits and appointment adherence – simplestgaps and HRSA HAB – calculation of the time interval between completed visitsConstancy – the observation period of interest be divided into intervals of interest

Page 14: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.

DiscussionSensitivity in capturing disease severity and stage of treatment

HRSA HAB, the gaps – insensitive in capturing retention as it relates to issues of disease severity and stage, and rather represents a minimum standard of retention in caremissed visit and appointment adherence – visit frequency reflects the disease severity and stage of treatment for each individual patientconstancy – the capacity to account for severity and stage of treatment through variation of the time interval

Page 15: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.

Future Direction

With growing emphasis on ‘‘test and treat’’ approaches to HIV prevention, there is a clear need for additional engagement in HIV care researchfuture research should evaluate the impact of such visits and their inclusion in HIV retention measures on patient outcomes

Page 16: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.

Conclusion

This article provides a synthesis of the most commonly used measures of retention in HIV care, their methodological and conceptual strengths and limitations, and suggests situations in which certain measures may be preferred over others